Aevumed
Malvern, US · Delaware corporation
Founders & leadership
SK
SAIF KHALILNamed on SEC filing
Board
DF
DAVID FARMERBoard director
WS
WILLIAM SHOPOFFBoard director
Reported raises · per SEC filings
Form D private placements$5.1M disclosed across 4 rounds · 2013–2021
▶$3MraisedJun 2025 · 36 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2025 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DAVID FARMERDirector
- SAIF KHALILExecutive Officer, Director
- WILLIAM SHOPOFFDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$305KraisedJun 2025 · 10 investors · BiotechnologyRule 506(b)
▶$305KraisedJun 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Saif KhalilExecutive Officer, Director
- Offering amount
- $305K
- Amount sold
- $305K
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$264KraisedJun 2025 · 10 investors · BiotechnologyRule 506(b)
▶$264KraisedJun 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SAIF KHALILExecutive Officer, Director
- Offering amount
- $264K
- Amount sold
- $264K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJun 2025 · 21 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2025 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SAIF KHALILExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Aevumed raised?
- Aevumed has disclosed $5.1M raised across 4 rounds.
- Where is Aevumed headquartered?
- Aevumed is headquartered in Malvern, US.